VIAVI Executives Sold About $1.7M as the Network-Test Story Improved
Two VIAVI executives sold about $1.7M across late 2025 to early 2026, a period when the company was benefiting from a better demand narrative than it had a year earlier.
Two VIAVI Solutions executives sold about $1.7M across the latest visible cluster, led by Kevin Siebert and Paul McNab. The timing matters because the sales came as VIAVI's demand narrative looked healthier than it had during the prior downturn.
What Happened
| Date | Insider | Code | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-02-02 | Kevin Siebert | S | 13,577 | $25.72 | $0.35M |
| 2025-12-08 | Kevin Siebert | S | 24,225 | $18.26 | $0.44M |
| 2025-11-03 | Kevin Siebert | S | 11,148 | $17.29 | $0.19M |
| 2026-03-02 | Paul McNab | S | 3,551 | $32.89 | $0.12M |
| 2026-02-02 | Paul McNab | S | 4,638 | $25.80 | $0.12M |
The point is not that $1.7M is enormous relative to the whole company. The point is that insiders were happy to monetize while the operating backdrop had become easier to explain. In industrial technology, that is usually when the market starts awarding a cleaner multiple.
Why It Matters
VIAVI sits in the network-test and optical ecosystem, which means the company is often judged against names like Keysight, Coherent, Lumentum, Ciena, and Amphenol. When insiders sell into a better tape, the most useful question is whether they are trimming into strength or signaling that the good news is already fully priced.
For now, the evidence looks more like monetization into improved sentiment than a dramatic distribution event. But clustered executive selling still matters because it tells you management was comfortable taking cash out while the setup felt friendlier.
How to Read the Signal
These are straightforward sale prints, not a bullish accumulation story. That does not make them automatically bearish. It does mean investors should watch whether the company keeps delivering enough demand evidence to offset insider monetization.
If future filings remain small and episodic, the market will probably ignore them. If the cadence broadens, it becomes a more interesting governance signal.
Key Facts
| Company | VIAVI Solutions |
|---|---|
| Primary insiders | Kevin Siebert and Paul McNab |
| Estimated cluster value | About $1.7M |
| Interpretation | Executive monetization into a stronger operating narrative |
What to Watch
- VIAVI orders and margin commentary: the business backdrop has to keep improving for these sales to remain a non-event.
- Peer read-through: compare the tape with Keysight, Coherent, and Lumentum.
- Executive cadence: whether future sells remain measured or broaden into a larger pattern.
- Customer spending: any slowdown in network and optical demand would make insider sales look more ominous.
- Valuation discipline: a healthier narrative often invites profit-taking even when the underlying business is still improving.
Related Research
Explore all researchSimplex Trading reported a $177.41B Q4 2025 13F, but the filing reads less like a stock portfolio and more like an options-heavy market-structure book. That distinction is the whole story.
Apr 1, 2026
Q1 2026 13F filings are due May 15, 2026. Track Berkshire, Millennium, Bridgewater and more. See expected filing dates, AI/sector themes, and how to access data the moment it drops.
Mar 31, 2026
Arrowstreet Capital's systematic models triggered one of Q4 2025's most aggressive Apple trims (-38% shares) while more than doubling Google. With 93 new positions and $170.74B in 13F assets, here's what the quant signals are saying.
Mar 30, 2026
The 220-year-old London-based asset manager's US equity book reveals a distinctly European conviction — GOOGL as the #3 holding at 6.03%, plus aggressive adds in TEVA (+261%), CX (+406%), and new global commodity ETF positions.
Mar 30, 2026
Janus Henderson (WhaleScore 75.50) opened 67 new positions while exiting 67 in Q4 2025 — a 13.4% turnover rate signaling active repositioning. New biotech/med-device bets (ISRG, GPCR, PTGX) hint at a healthcare conviction thesis.
Mar 30, 2026